ZA829344B - Interferon formulations - Google Patents

Interferon formulations

Info

Publication number
ZA829344B
ZA829344B ZA829344A ZA829344A ZA829344B ZA 829344 B ZA829344 B ZA 829344B ZA 829344 A ZA829344 A ZA 829344A ZA 829344 A ZA829344 A ZA 829344A ZA 829344 B ZA829344 B ZA 829344B
Authority
ZA
South Africa
Prior art keywords
interferon formulations
interferon
formulations
Prior art date
Application number
ZA829344A
Inventor
Henry King Hong Kwan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA829344B publication Critical patent/ZA829344B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
ZA829344A 1981-12-23 1982-12-20 Interferon formulations ZA829344B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33405281A 1981-12-23 1981-12-23

Publications (1)

Publication Number Publication Date
ZA829344B true ZA829344B (en) 1983-10-26

Family

ID=23305374

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA828580A ZA828580B (en) 1981-12-23 1982-11-19 Interferon formulations
ZA829344A ZA829344B (en) 1981-12-23 1982-12-20 Interferon formulations

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA828580A ZA828580B (en) 1981-12-23 1982-11-19 Interferon formulations

Country Status (3)

Country Link
JP (1) JPS58146504A (en)
KR (1) KR880002037B1 (en)
ZA (2) ZA828580B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228422A (en) * 1984-04-26 1985-11-13 Suntory Ltd Stabilized preparation of physiologically active substance
JPS60243028A (en) * 1984-04-28 1985-12-03 Kyowa Hakko Kogyo Co Ltd Solubilization of interferon
ATE50694T1 (en) * 1985-10-15 1990-03-15 Hoffmann La Roche STABILIZATION OF INTERFERONS.
JP2577744B2 (en) * 1986-07-18 1997-02-05 中外製薬株式会社 Stable granulocyte colony-stimulating factor containing preparation
JPS6391331A (en) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk Ophthalmic aqueous composition
CA1327161C (en) * 1987-09-01 1994-02-22 Mitsugu Kobayashi Lyophilized pharmaceutical composition of neocarzinostatin derivative
AU3857095A (en) * 1994-11-29 1996-06-19 Kyowa Hakko Kogyo Co. Ltd. Indolocarbazole derivative preparation
ATE326985T1 (en) * 2002-02-01 2006-06-15 Shimoda Biotech Pty Ltd LYOPHILIZED PHARMACEUTICAL COMPOSITION OF PROPOFOL
CU23432B6 (en) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon

Also Published As

Publication number Publication date
ZA828580B (en) 1983-10-26
KR880002037B1 (en) 1988-10-13
JPS58146504A (en) 1983-09-01
KR840002657A (en) 1984-07-16
JPH0543689B2 (en) 1993-07-02

Similar Documents

Publication Publication Date Title
IL67517A0 (en) Interferon formulations
HK53188A (en) Pharmaceutical formulations
DE3262847D1 (en) Heat-polymerisable compositions
ZA829344B (en) Interferon formulations
ZA844045B (en) Interferon gel formulations
DE3263502D1 (en) Flavour-release compositions
GB2105190B (en) Light-screen compositions
JPS57174020A (en) Combine
JPS57188524A (en) Interferon
JPS57174021A (en) Combine
JPS57198015A (en) Combine
JPS57198004A (en) Mowering combine
JPS57174018A (en) Combine
JPS57174019A (en) Combine
JPS57159415A (en) Combine
CS175282A2 (en) Herbicidni prostredek s prodlouzenou stalosti v pude
GB2105744B (en) Sulfur-aggregate compositions
JPS57174013A (en) Combine
JPS57177613A (en) Combine
JPS57189611A (en) Combine
JPS57174016A (en) Combine
JPS57202207A (en) Mowering combine
JPS57174017A (en) Combine
JPS57202208A (en) Mowering combine
JPS57198003A (en) Mowering combine